148 related articles for article (PubMed ID: 30810582)
1. Aptamer-guided acridine derivatives for cervical cancer.
Carvalho J; Lopes-Nunes J; Lopes AC; Cabral Campello MP; Paulo A; Queiroz JA; Cruz C
Org Biomol Chem; 2019 Mar; 17(11):2992-3002. PubMed ID: 30810582
[TBL] [Abstract][Full Text] [Related]
2. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
3. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
[TBL] [Abstract][Full Text] [Related]
4. RNA G-quadruplex as supramolecular carrier for cancer-selective delivery.
Santos T; Pereira P; Campello MPC; Paulo A; Queiroz JA; Cabrita E; Cruz C
Eur J Pharm Biopharm; 2019 Sep; 142():473-479. PubMed ID: 31325486
[TBL] [Abstract][Full Text] [Related]
5. G-quadruplex structure of an anti-proliferative DNA sequence.
Do NQ; Chung WJ; Truong THA; Heddi B; Phan AT
Nucleic Acids Res; 2017 Jul; 45(12):7487-7493. PubMed ID: 28549181
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent light-up acridine orange derivatives bind and stabilize KRAS-22RT G-quadruplex.
Carvalho J; Pereira E; Marquevielle J; Campello MPC; Mergny JL; Paulo A; Salgado GF; Queiroz JA; Cruz C
Biochimie; 2018 Jan; 144():144-152. PubMed ID: 29129745
[TBL] [Abstract][Full Text] [Related]
7. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
[TBL] [Abstract][Full Text] [Related]
8. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes.
Musumeci D; Amato J; Zizza P; Platella C; Cosconati S; Cingolani C; Biroccio A; Novellino E; Randazzo A; Giancola C; Pagano B; Montesarchio D
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1341-1352. PubMed ID: 28130159
[TBL] [Abstract][Full Text] [Related]
9. Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.
Riccardi C; Musumeci D; Russo Krauss I; Piccolo M; Irace C; Paduano L; Montesarchio D
Int J Biol Macromol; 2018 Oct; 118(Pt B):1384-1399. PubMed ID: 30170359
[TBL] [Abstract][Full Text] [Related]
10. Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells.
Ogloblina AM; Khristich AN; Karpechenko NY; Semina SE; Belitsky GA; Dolinnaya NG; Yakubovskaya MG
Biochimie; 2018 Feb; 145():163-173. PubMed ID: 29208488
[TBL] [Abstract][Full Text] [Related]
11. Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.
Mosafer J; Mokhtarzadeh A
Curr Drug Deliv; 2018; 15(9):1323-1329. PubMed ID: 30039760
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiproliferative activity of 2,7-diamino l0-(3,5-dimethoxy)benzyl-9(10H)-acridone derivatives as potent telomeric G-quadruplex DNA ligands.
Gao C; Zhang W; He S; Li S; Liu F; Jiang Y
Bioorg Chem; 2015 Jun; 60():30-6. PubMed ID: 25912692
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 7-substituted-5,6-dihydrobenzo[c]acridine derivatives as new c-KIT promoter G-quadruplex binding ligands.
Guo QL; Su HF; Wang N; Liao SR; Lu YT; Ou TM; Tan JH; Li D; Huang ZS
Eur J Med Chem; 2017 Apr; 130():458-471. PubMed ID: 28284084
[TBL] [Abstract][Full Text] [Related]
14. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.
Bates PJ; Reyes-Reyes EM; Malik MT; Murphy EM; O'Toole MG; Trent JO
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1414-1428. PubMed ID: 28007579
[TBL] [Abstract][Full Text] [Related]
15. Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.
Sharma VR; Thomas SD; Miller DM; Rezzoug F
Cancer Invest; 2018; 36(9-10):475-491. PubMed ID: 30396283
[TBL] [Abstract][Full Text] [Related]
16. DNA Polymer Nanoparticles Programmed via Supersandwich Hybridization for Imaging and Therapy of Cancer Cells.
Li N; Xiang MH; Liu JW; Tang H; Jiang JH
Anal Chem; 2018 Nov; 90(21):12951-12958. PubMed ID: 30303006
[TBL] [Abstract][Full Text] [Related]
17. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
19. Rational design of acridine-based ligands with selectivity for human telomeric quadruplexes.
Sparapani S; Haider SM; Doria F; Gunaratnam M; Neidle S
J Am Chem Soc; 2010 Sep; 132(35):12263-72. PubMed ID: 20718414
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative activity of 9-benzylamino-6-chloro-2-methoxy-acridine derivatives as potent DNA-binding ligands and topoisomerase II inhibitors.
Zhang W; Zhang B; Zhang W; Yang T; Wang N; Gao C; Tan C; Liu H; Jiang Y
Eur J Med Chem; 2016 Jun; 116():59-70. PubMed ID: 27060757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
